These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 35908888)
1. Role of Nrf2 in Methotrexate-Induced Epithelial-Mesenchymal Transition in Alveolar A549 Cells. Kawami M; Honda M; Hara T; Yumoto R; Takano M Biol Pharm Bull; 2022; 45(8):1069-1076. PubMed ID: 35908888 [TBL] [Abstract][Full Text] [Related]
2. Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells. Yamagami Y; Kawami M; Ojima T; Futatsugi S; Yumoto R; Takano M Biochem Biophys Res Commun; 2020 May; 525(3):543-548. PubMed ID: 32113686 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate-Induced Epithelial-Mesenchymal Transition in the Alveolar Epithelial Cell Line A549. Kawami M; Harabayashi R; Miyamoto M; Harada R; Yumoto R; Takano M Lung; 2016 Dec; 194(6):923-930. PubMed ID: 27604426 [TBL] [Abstract][Full Text] [Related]
4. Melatonin prevents LPS-induced epithelial-mesenchymal transition in human alveolar epithelial cells via the GSK-3β/Nrf2 pathway. Ding Z; Wu X; Wang Y; Ji S; Zhang W; Kang J; Li J; Fei G Biomed Pharmacother; 2020 Dec; 132():110827. PubMed ID: 33065391 [TBL] [Abstract][Full Text] [Related]
5. Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis. Ohbayashi M; Kubota S; Kawase A; Kohyama N; Kobayashi Y; Yamamoto T J Toxicol Sci; 2014 Apr; 39(2):319-30. PubMed ID: 24646714 [TBL] [Abstract][Full Text] [Related]
6. Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3. Takano M; Yamamoto C; Yamaguchi K; Kawami M; Yumoto R Drug Metab Pharmacokinet; 2015 Feb; 30(1):111-8. PubMed ID: 25760538 [TBL] [Abstract][Full Text] [Related]
7. Role of integrin α2 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells. Kawami M; Ojima T; Yumoto R; Takano M Toxicol Res; 2022 Oct; 38(4):449-458. PubMed ID: 36277370 [TBL] [Abstract][Full Text] [Related]
8. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells Zhang CY; Guan XX; Song ZH; Jiang HL; Liu YB; Chen P; Duan JX; Zhou Y Oxid Med Cell Longev; 2022; 2022():5759626. PubMed ID: 35509835 [TBL] [Abstract][Full Text] [Related]
9. Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase. Kawami M; Honda N; Hara T; Yumoto R; Takano M Drug Metab Pharmacokinet; 2019 Dec; 34(6):396-399. PubMed ID: 31601464 [TBL] [Abstract][Full Text] [Related]
10. Polydatin attenuates reactive oxygen species-induced airway remodeling by promoting Nrf2-mediated antioxidant signaling in asthma mouse model. Zeng H; Wang Y; Gu Y; Wang J; Zhang H; Gao H; Jin Q; Zhao L Life Sci; 2019 Feb; 218():25-30. PubMed ID: 30092299 [TBL] [Abstract][Full Text] [Related]
11. Role of miR-34a in TGF-β1- and Drug-Induced Epithelial-Mesenchymal Transition in Alveolar Type II Epithelial Cells. Takano M; Nekomoto C; Kawami M; Yumoto R J Pharm Sci; 2017 Sep; 106(9):2868-2872. PubMed ID: 28408209 [TBL] [Abstract][Full Text] [Related]
12. Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549. Kawami M; Harabayashi R; Harada R; Yamagami Y; Yumoto R; Takano M Biochem Biophys Res Commun; 2018 Feb; 497(1):457-463. PubMed ID: 29448106 [TBL] [Abstract][Full Text] [Related]
13. Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells. Ojima T; Kawami M; Yumoto R; Takano M Toxicol Res; 2021 Jul; 37(3):293-300. PubMed ID: 34295794 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF. Qu J; Zhang Z; Zhang P; Zheng C; Zhou W; Cui W; Xu L; Gao J J Cell Physiol; 2019 Jun; 234(6):8862-8872. PubMed ID: 30370641 [TBL] [Abstract][Full Text] [Related]
15. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis. Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432 [TBL] [Abstract][Full Text] [Related]
16. Involvement of Nrf2-GSH signaling in TGFβ1-stimulated epithelial-to-mesenchymal transition changes in rat renal tubular cells. Ryoo IG; Shin DH; Kang KS; Kwak MK Arch Pharm Res; 2015 Feb; 38(2):272-81. PubMed ID: 24849033 [TBL] [Abstract][Full Text] [Related]
17. Anticancer Drug-Induced Epithelial-Mesenchymal Transition via p53/miR-34a axis in A549/ABCA3 Cells. Yamamoto A; Kawami M; Konaka T; Takenaka S; Yumoto R; Takano M J Pharm Pharm Sci; 2019; 22(1):516-524. PubMed ID: 31603744 [TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling. Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614 [TBL] [Abstract][Full Text] [Related]
19. LncRNA Ye W; Ma J; Wang F; Wu T; He M; Li J; Pei R; Zhang L; Wang Y; Zhou J Oxid Med Cell Longev; 2020; 2020():8184314. PubMed ID: 33274006 [TBL] [Abstract][Full Text] [Related]
20. Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells. Kawami M; Harada R; Ojima T; Yamagami Y; Yumoto R; Takano M Toxicology; 2019 Aug; 424():152231. PubMed ID: 31170432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]